Effects of Relaxing Breathing Combined With Biofeedback on the Performance and Stress of Residents During HFS (RETROSIMU)

May 16, 2021 updated by: Lilot Marc, Claude Bernard University

Effects of Relaxing Breathing Combined With Biofeedback on the Performance and Stress of Residents During a High-fidelity Simulation Session.

The harmful effects of stress on health professionals are expressed both in terms of their health (physical or mental) and the quality of work (reduced memory capacity, deterioration in patient care). These adverse effects highlight the importance of implementing effective coping strategies and/or early learning of stress management methods in medical training programs.

Relaxation breathing techniques coupled with heart rate variability (HRV) biofeedback is one of the new techniques used to reduce the stress level.

No research has yet tested the effects of HRV induced by relaxation breathing technique before managing a simulated critical situation.

Study Overview

Detailed Description

This is a randomized, controlled study conducted at the university simulation centre in healthcare of Lyon, France. The high-fidelity simulation (HFS) will be used as a research tool and the topics included will be the HFS residents summoned to critical care situations as part of their training curriculum. The study has received prior approval from the UCBL1. Ethics Committee. After information (protocol and objective of the study), signature of consent, and one minute of relaxing breathing training, the residents as active participants in HFS, will be included in the study. They will be equipped with Hexoskin® jackets collecting heart rate, heart rate variability, breathing rate continuously and an Empathica® connected watch for continuous measurement of electrodermal activity. Then each resident will be randomized into one of the three intervention groups that are:

  • a relaxing breathing exercise coupled with biofeedback
  • a breathing exercise without biofeedback
  • a control occupation (observation of normal biological results). Each intervention will last five minutes and will be conducted between the briefing and the scenario.

Main objective :

The objective of this study is to compare during HFS, the performance of residents during critical care scenarios. The performance analysis will be performed by two independent and blinded evaluators, based on the video recordings of scenarios. The overall performance will be the addition of technical skills (specific rating grid for each scenario on 100 pts) and non-technical skills assessed by the OTTAWA GRS grid (adjusted to 100 pts).

Secondary objectives :

  • Compare the effects of the three interventions on reducing psychological stress.
  • Compare the effects of the three interventions on reducing physiological stress.
  • Compare the effects of the three interventions on increasing cardiac coherence scores.

Study Type

Interventional

Enrollment (Actual)

156

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rhône-Alpes
      • Lyon, Rhône-Alpes, France, 69007
        • CLESS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult person
  • Registered in specialized diploma of medical training.
  • Invited for a high-fidelity simulation session at the Lyon university simulation center.
  • Have signed an informed consent form.

Exclusion Criteria:

  • pregnant woman

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
SHAM_COMPARATOR: Control
5 minutes of reading fictitious biological medical results that are almost normal and unrelated to the upcoming scenario. This condition reflects a likely activity in relation to other patients in charge, pending an announced critical situation.
5 minutes of reading fictitious biological medical results
ACTIVE_COMPARATOR: Relaxing Breathing
5 minutes of relaxing breathing guided by a computer helping to follow inspiration and expiration.
5 minutes of relaxing breathing guided by a computer helping to follow inspiration and expiration.
EXPERIMENTAL: Breathing exercise combined with HRV
5 minutes of relaxing breathing, guided by a computer helping to follow inspiration and expiration and coupled with direct biological feedback on HRV.
5 min of relaxing breathing, coupled with biological feedback.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Performance during HFS
Time Frame: day 0: during the HFS
Technical specific performance for each scenario. Non-technical performance (with Ottawa GRS Grid).
day 0: during the HFS

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physiological stress
Time Frame: day 0: during the HFS
HRV
day 0: during the HFS
Psychological stress
Time Frame: 0: during the HFS
Visual analog scales from 0 to 100 mm the higher the higher stress level
0: during the HFS
Individual psychological characteristics
Time Frame: 0: during the HFS
Personality traits (Big-5)
0: during the HFS
psychological stress consequences
Time Frame: 0: during the HFS
Activation-Desactivation Adjective Check List: for the four subscales: Energy, Tiredness, Tension , and Calmness
0: during the HFS
Individual psychological characteristics
Time Frame: 0: during the HFS
Depressive symptoms (Beck) the higher the more depressive symptoms Anxiety-Trait (STAI-T)
0: during the HFS
Individual psychological characteristics
Time Frame: 0: during the HFS
Fear of negative evaluation (PEN). from 0 to 30 the higher the more fear
0: during the HFS
Physiological stress
Time Frame: day 0: during the HFS
electrodermal activity
day 0: during the HFS

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 1, 2019

Primary Completion (ACTUAL)

June 30, 2020

Study Completion (ACTUAL)

June 30, 2020

Study Registration Dates

First Submitted

October 23, 2019

First Submitted That Met QC Criteria

October 24, 2019

First Posted (ACTUAL)

October 28, 2019

Study Record Updates

Last Update Posted (ACTUAL)

May 18, 2021

Last Update Submitted That Met QC Criteria

May 16, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RETROSIMU

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress, Psychological

Clinical Trials on Control

3
Subscribe